The ECM and cancer cells reprogram resident immune cells, generating a pro-inflammatory environment promoted by cytokines like interleukin 6 (IL-6) and interleukin 8 (IL-8) [8,13,20]. The gene discussed is CXCL8; the disease is cancer.